These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 185452)

  • 1. [Plasma-cAMP in primary and secondary hyperparathyroidism (author's transl)].
    Endres P; Happ J; Köhler H; Fiegel P
    Klin Wochenschr; 1976 Oct; 54(20):1005-6. PubMed ID: 185452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Radioimmunologic determination of circulating parathyroid hormone in patients with primary and secondary hyperparathyroidism].
    Lo Giudice C; Cascone C; Manente P; Gasparoni P; De Luca M; Rota G; Conte N
    Minerva Med; 1982 Dec; 73(48):3425-8. PubMed ID: 7177469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunoreactive parathyroid hormone in samples from thyroid veins (author's transl)].
    Offermann G; Sörensen R; Häring R
    Klin Wochenschr; 1978 Oct; 56(20):1007-12. PubMed ID: 723182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Primary hyperparathyroidism: clinical and laboratory aspects (author's transl)].
    Furukawa Y
    Horumon To Rinsho; 1981 Nov; 29(11):1331-6. PubMed ID: 6280906
    [No Abstract]   [Full Text] [Related]  

  • 5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hyperparathyroidism in hemodialysis patients: studies on parathyroid regulation and classification problems (author's transl)].
    Augustin R; Hackeng WH
    Klin Wochenschr; 1981 Nov; 59(22):1251-9. PubMed ID: 7311395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aseptic necrosis of bone following renal transplantation: relation with hyperparathyroidism.
    Nehme D; Rondeau E; Paillard F; Moreau JF; Nussaume O; Kanfer A; Sraer JD
    Nephrol Dial Transplant; 1989; 4(2):123-8. PubMed ID: 2540458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A theoretical analysis of the steady-state relationship between plasma concentrations of calcium and parathyroid hormone.
    Walton RJ
    Med Hypotheses; 1977; 3(1):1-3. PubMed ID: 853970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cyclic adenosine monophosphate and renal failure (author's transl)].
    Schneider W; Szántó T; Truat G
    Klin Wochenschr; 1974 Dec; 52(24):1175-6. PubMed ID: 4376190
    [No Abstract]   [Full Text] [Related]  

  • 10. Circulating molecular forms of parathyroid hormone in primary and secondary hyperparathyroidism.
    Brandão CM; Kasamatsu TS; Oliveira MA; Vieira JG
    Braz J Med Biol Res; 1989; 22(8):963-5. PubMed ID: 2633848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of C-terminal and N-terminal PTH in secondary hyperparathyroidism in renal failure.
    Hortling L; Puutula-Räsänen L; Fyhrquist F
    Scand J Urol Nephrol Suppl; 1985; 90():51-4. PubMed ID: 3868028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum calcium, parathyroid hormone, and urinary cyclic adenosine monophosphate after parathyroidectomy.
    Kaplan EL; Fang VS; Sugimoto J; Fredland A
    Surgery; 1982 Nov; 92(5):822-6. PubMed ID: 6291182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients.
    Nakanishi S; Kazama JJ; Nii-Kono T; Omori K; Yamashita T; Fukumoto S; Gejyo F; Shigematsu T; Fukagawa M
    Kidney Int; 2005 Mar; 67(3):1171-8. PubMed ID: 15698459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary hyperparathyroidism in patients on maintenance hemodialysis: study of the N and C-terminal parathyroid hormones.
    Hida M; Shimbo T; Nakamura K; Wakabayashi T; Saitoh H; Satoh T
    Tokai J Exp Clin Med; 1983 Jul; 8(3):225-8. PubMed ID: 6670108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Improvement of the preoperative localization technique in the surgery of hyperparathyroidism (author's transl)].
    Klempa I; Palau V; Schwedes V; Usadel KH
    MMW Munch Med Wochenschr; 1977 Aug; 119(31):1007-10. PubMed ID: 408640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nephrogenous cyclic AMP levels in primary hyperparathyroidism.
    Babka JC; Bower RH; Sode J
    Arch Intern Med; 1976 Oct; 136(10):1140-4. PubMed ID: 184749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Raised cAMP content of striated muscle in experimental chronic renal failure (author's transl)].
    Schmidt G; Fricke L; Hempel K; Heidland A
    Dtsch Med Wochenschr; 1975 Nov; 100(46):2397-8. PubMed ID: 171131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of acute cimetidine administration on indices of parathyroid hormone action in healthy subjects and patients with primary and secondary hyperparathyroidism.
    Glaser B; Kraiem Z; Rotem M; Gonda M; Bernheim J; Sheinfeld M
    J Clin Endocrinol Metab; 1984 Nov; 59(5):993-7. PubMed ID: 6090499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary cyclic AMP. Relation to albumin-corrected serum calcium in healthy persons and patients with primary hyperparathyroidism.
    Madsen SN; Badawi I; Jorgensen FS; Skovsted L; Transbol I
    Acta Med Scand; 1976; 200(3):195-9. PubMed ID: 184691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the molecular forms of immunoreactive parathyroid hormone in primary hyperparathyroidism and in hyperparathyroidism due to renal failure.
    Gautvik KM; Gautvik VT; Halvorsen JF
    Scand J Clin Lab Invest; 1983 Nov; 43(7):553-64. PubMed ID: 6658372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.